BioCryst Pharma (BCRX) – Guidance
-
BioCryst Pharma (BCRX) Misses Q4 EPS by 3c ; Offers Guidance
-
BioCryst Pharma (BCRX) Reports Prelim FY23 ORLADEYO Sales of $325M
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BCRX Stock Lookup